Effectiveness and safety of omalizumab in chronic spontaneous or inducible urticaria: evaluation of 154 patients

Br J Dermatol. 2016 Aug;175(2):404-6. doi: 10.1111/bjd.14540. Epub 2016 May 14.

Authors

M N Ghazanfar¹, C Sand¹, S F Thomsen^{1

2}

Affiliations

¹ Department of Dermatology, Bispebjerg Hospital, Copenhagen, Denmark.
² Center for Medical Research Methodology, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.

PMID: 26972689
DOI: 10.1111/bjd.14540

No abstract available

Publication types

Letter

MeSH terms

Adult
Anti-Allergic Agents / administration & dosage*
Anti-Allergic Agents / adverse effects
Chronic Disease
Drug Administration Schedule
Female
Humans
Male
Omalizumab / administration & dosage*
Omalizumab / adverse effects
Retrospective Studies
Treatment Outcome
Urticaria / drug therapy*

Substances

Anti-Allergic Agents
Omalizumab